Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy
NCT05138757
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Peanut Allergy
Interventions
DRUG:
Prebiotic
DRUG:
Placebo
Sponsor
University of Chicago